Cargando…

Protective effect of Shenmai injection on doxorubicin-induced cardiotoxicity via regulation of inflammatory mediators

BACKGROUND: Doxorubicin (DOX) is a chemotherapy drug for malignant tumors. The clinical application of DOX is limited due to its dosage relative cardiotoxicity. Oxidative damage and cardiac inflammation appear to be involved in DOX-related cardiotoxicity. Shenmai injection (SMI), which mainly consis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Sheng, You, Zhen-Qiang, Yang, Lin, Li, Li-Li, Wu, You-Ping, Gu, Li-Qiang, Xin, Yan-Fei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6862794/ https://www.ncbi.nlm.nih.gov/pubmed/31744501 http://dx.doi.org/10.1186/s12906-019-2686-2

Ejemplares similares

Shenmai Injection Protects Against Doxorubicin-Induced Cardiotoxicity via Maintaining Mitochondrial Homeostasis
por: Li, Lin, et al.
Publicado: (2020)

Pretreatment with Shenmai Injection Protects against Coronary Microvascular Dysfunction
por: Zheng, Zhaohai, et al.
Publicado: (2022)

Investigation of cardiovascular protective effect of Shenmai injection by network pharmacology and pharmacological evaluation
por: Li, Lin, et al.
Publicado: (2020)

Shenmai injection ameliorates doxorubicin-induced myocardial injury by suppressing autophagy-apoptosis via miR-30a
por: Li, Yanyang, et al.
Publicado: (2023)

Quality monitoring of Shenmai injection by HPLC pharmacodynamic fingerprinting
por: Yang, Geng, et al.
Publicado: (2023)

Anaphylactoid reactions induced by Shuanghuanglian injection and Shenmai injection and metabolomics analysis
por: Zhang, Chi, et al.
Publicado: (2023)

In vivo and in vitro protective effects of shengmai injection against doxorubicin-induced cardiotoxicity
por: Zhou, Peng, et al.
Publicado: (2022)

An Overview of Systematic Reviews of Shenmai Injection for Healthcare
por: Lu, Ling-yan, et al.
Publicado: (2014)

Harpagoside Protects Against Doxorubicin-Induced Cardiotoxicity via P53-Parkin-Mediated Mitophagy
por: Li, Weili, et al.
Publicado: (2022)

Effects of Shenmai injection and its bioactive components following ischemia/reperfusion in cardiomyocytes
por: YE, LI-FANG, et al.
Publicado: (2015)

Adjuvant Application of Shenmai Injection for Sepsis: A Systematic Review and Meta-Analysis
por: Sun, Ye, et al.
Publicado: (2022)

Understanding the Protective Role of Exosomes in Doxorubicin-Induced Cardiotoxicity
por: Zhang, Guoxia, et al.
Publicado: (2022)

Shenmai injection suppresses multidrug resistance in MCF-7/ADR cells through the MAPK/NF-κB signalling pathway
por: Yang, Lin, et al.
Publicado: (2020)

Efficacy of Shenmai injection for the treatment of chronic heart failure: A protocol of systematic review
por: Gao, Peng, et al.
Publicado: (2020)

Asiatic Acid Protects against Doxorubicin-Induced Cardiotoxicity in Mice
por: Hu, Xiaoping, et al.
Publicado: (2020)

Comparison of Protective Effects of Shenmai Injections Produced by Medicinal Materials from Different Origins on Cardiomyocytes
por: Zhao, Min, et al.
Publicado: (2022)

Shenmai Injection Improves Energy Metabolism in Patients With Heart Failure: A Randomized Controlled Trial
por: Wang, Shao-mei, et al.
Publicado: (2020)

Effect of Shenmai injection on preventing the development of nitroglycerin-induced tolerance in rats
por: Zhou, Qian, et al.
Publicado: (2017)

INKing the Cardiotoxicity Out of Doxorubicin
por: Guo, Zhen, et al.
Publicado: (2023)

Chrysophanol protects against doxorubicin-induced cardiotoxicity by suppressing cellular PARylation
por: Lu, Jing, et al.
Publicado: (2019)

Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine
por: Cheah, Irwin K., et al.
Publicado: (2023)

Anti-Inflammatory Effects and Molecular Mechanisms of Shenmai Injection in Treating Acute Pancreatitis: Network Pharmacology Analysis and Experimental Verification
por: He, Yanqiu, et al.
Publicado: (2022)

The clinical efficacy of Shenmai injection in the prophylaxis and treatment of intradialytic hypotension: A protocol for systematic review and meta-analysis
por: Xiang, Zhen, et al.
Publicado: (2022)

Liquiritigenin-Loaded Submicron Emulsion Protects Against Doxorubicin-Induced Cardiotoxicity via Antioxidant, Anti-Inflammatory, and Anti-Apoptotic Activity
por: Shi, Changcan, et al.
Publicado: (2020)

Resveratrol, a polyphenol phytoalexin, protects against doxorubicin-induced cardiotoxicity
por: Gu, Jun, et al.
Publicado: (2015)

Levosimendan Protects against Doxorubicin-Induced Cardiotoxicity by Regulating the PTEN/Akt Pathway
por: Li, Ling-Li, et al.
Publicado: (2020)

Investigating the effect of Shenmai injection on cardiac electrophysiology and calcium signaling using human-induced pluripotent stem cell-derived cardiomyocytes
por: Zhang, Zhang, et al.
Publicado: (2022)

Therapeutic efficacy of shenmai injection as an adjuvant treatment in dilated cardiomyopathy: A protocol for systematic review
por: Gao, Kai, et al.
Publicado: (2020)

Nrf2-dependent antioxidant response mediated the protective effect of tanshinone IIA on doxorubicin-induced cardiotoxicity
por: Guo, Zhaohui, et al.
Publicado: (2018)

Mulberrin Confers Protection against Doxorubicin-Induced Cardiotoxicity via Regulating AKT Signaling Pathways in Mice
por: Ye, Peng, et al.
Publicado: (2022)

The Neuroprotective Effect of Shenmai Injection on Oxidative Stress Injury in PC12 Cells Based on Network Pharmacology
por: Wu, Jing, et al.
Publicado: (2022)

Carbohydrates and ginsenosides in shenmai injection jointly improve hematopoietic function during chemotherapy-induced myelosuppression in mice
por: Zhang, Shiyu, et al.
Publicado: (2022)

Protective Effects of Dexrazoxane against Doxorubicin-Induced Cardiotoxicity: A Metabolomic Study
por: QuanJun, Yang, et al.
Publicado: (2017)

Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat
por: Hole, Lisa Drange, et al.
Publicado: (2014)

Protective effect of silymarin on doxorubicin-induced cardiotoxicity in rats
por: Stilinović, Nebojša, et al.
Publicado: (2012)

Protective effect of nebivolol on doxorubicin-induced cardiotoxicity in rats
por: Mohamed, Enas Ahmed, et al.
Publicado: (2018)

Dapagliflozin May Protect Against Doxorubicin-Induced Cardiotoxicity
por: Ulusan, Sebahat, et al.
Publicado: (2023)

Cardiomyocyte Atrophy, an Underestimated Contributor in Doxorubicin-Induced Cardiotoxicity
por: Chen, De-Shu, et al.
Publicado: (2022)

Authentication and distinction of Shenmai injection with HPLC fingerprint analysis assisted by pattern recognition techniques
por: Lu, Xue-Feng, et al.
Publicado: (2012)

Role of acetylation in doxorubicin-induced cardiotoxicity
por: Li, Daisong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c6pm837b5g0hfvqh26ec0snskf